Nuritas
PrivateLast Round
Series C
Dec 20, 2024
Total Funding Raised
$146.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nuritas operates in Healthcare & Life Sciences and is based in Dublin. Its latest recorded funding round was a Series C round in December 2024.
Nuritas is a biotechnology company that utilizes a platform combining artificial intelligence and genomics to discover and unlock natural bioactive peptides for use in dietary supplements, functional foods, and cosmetics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuritas Comparables
Compare Nuritas with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shiru | 87% | |
| Brightseed | 83% | |
| Protera | 81% |
For institutional investors. Book with your work email.
Nuritas Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 20, 2024 | ||||
| Series B | Nov 11, 2021 | ||||
| Debt | Nov 29, 2018 | ||||
| Series A | Dec 20, 2017 | ||||
| Seed | Dec 7, 2016 | ||||
Seed | Oct 26, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nuritas Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cultivian Sandbox Ventures | Series B, Series A |
| Grosvenor Food & AgTech | Series C, Series B |
| McWin Capital Partners | Series C |
| European Investment Bank Group | Debt |
| M&G Investments | Series C |
| Cleveland Avenue | Series B |
| Clay Capital | Series A, Seed, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 36% MoM, from 12.4K to 16.9K.
- May 5, 2026
Exhibiting at Vitafoods Europe 2026 in Barcelona.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withNov 11, 2026
On Nov 10th '26 in Ireland, Nuritas announces a partnership with University of Limerick under which it becomes a founding industry residency partner in the Immersive Bioscience and Biotherapeutics (iBio) programme.
- hiresSep 10, 2026
On Sep 10th '26 in Ireland, Nuritas appoints former Unilever North America President Kees Kruythoff as Chair of its Board of Directors to bring global scaling and commercialization expertise to the biotech company.
For institutional investors. Book with your work email.
Nuritas Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nuritas's valuation, stock price, and market status.
Is Nuritas a public or private company?
Nuritas is a private company.
What is the current stock price of Nuritas?
Nuritas is a private company, so its shares have no public market price. Caplight tracks Nuritas's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nuritas worth (valuation)?
Valuation information for Nuritas is not publicly available.
Can I buy Nuritas stock?
Nuritas shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nuritas's last funding round?
Nuritas's most recent funding round was Series C on December 20, 2024.
Who are the main investors in Nuritas?
Key investors in Nuritas include Cultivian Sandbox Ventures, M&G Investments, Cleveland Avenue, Clay Capital.
Will Nuritas IPO soon?
No public IPO plans have been announced for Nuritas.
How can I track Nuritas secondary market activity?
Caplight tracks bids, offers, and trades in Nuritas's shares on secondary markets.